MED GEN INC
10QSB, EX-27, 2000-08-14
PHARMACEUTICAL PREPARATIONS
Previous: MED GEN INC, 10QSB, 2000-08-14
Next: FRONTIERVISION HOLDINGS CAPITAL CORP, 10-Q, 2000-08-14



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This Summary Financial Data Schedule contains summary financial information
extracted from Balance Sheet,  Statement of Cash Flows, Statement of Operations
and Notes thereto incorporated in Part I, Item 1 of this Form 10-QSB and is
qualified in its entirety by reference to such financial statements.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          SEP-30-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                          52,761
<SECURITIES>                                         0
<RECEIVABLES>                                  188,133
<ALLOWANCES>                                   168,580
<INVENTORY>                                     88,193
<CURRENT-ASSETS>                               497,667
<PP&E>                                          46,564
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                 636,401
<CURRENT-LIABILITIES>                          453,755
<BONDS>                                              0
                                0
                                          0
<COMMON>                                         4,375
<OTHER-SE>                                     182,646
<TOTAL-LIABILITY-AND-EQUITY>                   636,401
<SALES>                                        264,876
<TOTAL-REVENUES>                               264,876
<CGS>                                           41,193
<TOTAL-COSTS>                                   41,193
<OTHER-EXPENSES>                               331,933
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                              (108,250)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (108,250)
<EPS-BASIC>                                     (0.02)
<EPS-DILUTED>                                   (0.02)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission